Imran Mir A's Transactions in Rani Therapeutics Holdings, Inc.

Imran Mir A, a director and ten percent owner of Rani Therapeutics Holdings, Inc., reported significant transactions involving the company's securities. On October 23, 2025, Mir acquired 2,083,334 shares of Class A Common Stock at a price of $0.605 per share through a PIPE offering. Additionally, Mir acquired 2,083,334 warrants to purchase Class A Common Stock, exercisable at $0.48 per share upon stockholder approval. These warrants have a five-year term from the date of such approval. Mir also holds 74,139 shares of Class A Common Stock and 22,660,053 shares of Class B Common Stock indirectly through various entities. Mir disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.